Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A Print this issue
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF Dec. 5, 2014 | Archived Issues

Get Ready for Joint Commission's Visit

The Joint Commission is due to visit before the end of the year, and there are only two eligible weeks remaining. Please review the following reminders that have been published previously in Medical Staff Pulse. Thank you for your cooperation and support in ensuring a successful survey.

» Read more

Physician Advocates Serve as Attendings' Eyes, Ears

With a role in patient care so new it is literally being defined at Cedars-Sinai, Bill Stanford, MD — a physician advocate — spends a fair amount of time explaining what he does. That's fine with him. As medical director of the Physician Advocate Program, Stanford welcomes the opportunity to discuss how physician advocates are making a difference in quality, efficiency and patient satisfaction.

» Read more

POLST Form Gets an Update for 2014

The California form for Physician Orders for Life-Sustaining Treatment has been revised for 2014, after five years of clinical experience and data collection, to be clearer and more accessible to patients and physicians.

» Read more

CS-Link Tip: Epic Earth

Have you ever tried to find a better way to do something in CS-Link™? Have you wondered what that globe on your top toolbar was? The answer to both questions is Epic Earth.

» Read more

Cancer Panel to Begin Referrals to Peer Review

Since its launch in January 2012, the Cedars-Sinai Cancer Quality Committee has provided leadership and oversight of the quality of clinical care, safety and satisfaction for patients with cancer. The committee has been sending educational letters to physicians whose inpatients' care falls outside of national quality standards and Cedars-Sinai practice. Starting in January, repeat offenders will be sent to medical staff peer review.

» Read more

FDA Warns About Lenalidomide, Duloxetine Hydrochloride, Peginterferon Alfa-2a

Pharmacy Focus

The U.S. Food and Drug Administration has issued warnings about the cancer drug lenalidomide, the antidepressant duloxetine hydrochloride and the hepatitis C drug peginterferon alfa-2a.

» Read more

Night at the Aquarium Set for Feb. 7

Medical staff members and their families are invited to a Night at the Aquarium, a dinner and sleepover at the Aquarium of the Pacific in Long Beach, on Saturday, Feb. 7, starting at 7 p.m.

» Read more

'Lung Coil' Device May Help Emphysema Patients

Cedars-Sinai thoracic surgeons are evaluating an investigational device that, with a relatively simple procedure, could bring significant relief to patients who suffer from severe emphysema.
 

» Read more

Cedars-Sinai Works to Meet TJC Alarm-Safety Goal

Cedars-Sinai has taken several steps to meet a new national patient safety goal on clinical alarm safety established by the Joint Commission.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news